Insider · CIK 0001867539
Andrew David Levin
Files at CLYM (Climb Bio, Inc.), VOR (Vor Biopharma Inc.). First filing -, latest -.
Andrew David Levin files SEC Form 4 as director at CLYM (Climb Bio, Inc.), and also at VOR (Vor Biopharma Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew David Levin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | CLYM Climb Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 8, 2026 |
| Dec 18, 2025 | VOR Vor Biopharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Dec 19, 2025 |
| Jun 4, 2025 | CLYM Climb Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 5, 2025 |
Questions about Andrew David Levin
Answered from the filings on this page, as of the latest one.
Is Andrew David Levin buying or selling?
Andrew David Levin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew David Levin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew David Levin has 0.
Where does Andrew David Levin file Form 4?
Andrew David Levin has filed Form 4 at CLYM (Climb Bio, Inc.); VOR (Vor Biopharma Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.